Delivery Order SPE2DB24D2215-SPE2DB25FGTHL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 19, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count) on August 11, 2025, with completion scheduled for September 2, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price contract represents a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $31,892.74 delivery order to AmerisourceBergen Drug Corp for TAGRISSO (80 mg tablets, 30-count package) under a firm fixed-price contract type. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, and represents a competitively awarded non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, leveraging its established...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packages) on July 14, 2025, with a completion date of August 4, 2025. This contract represents a firm fixed-price, non-set-aside award executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packaging) with an ultimate completion date of October 3, 2025. This non-set-aside contract was awarded competitively on September 12, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packages) on August 11, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count units) valued at $10,641.07 under a firm fixed-price contract type. The contract, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of TAGRISSO 40 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,641.07 and an ultimate completion date of September 17, 2025. The contract utilizes no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB25FGTHLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key provider within DLA's pharmaceutical procurement operations for federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 9/3/25 |